Evotec SE (EVOTF) Non Operating Income (2020 - 2025)
Evotec SE's (EVOTF) quarterly Non Operating Income came in at $1802.7 in Q3 2025, up 108.05% year-on-year from $866.45 in Q3 2024, and up 108.05% quarter-over-quarter from -$22382.8 in Q3 2024.
Evotec SE (EVOTF) Non Operating Income (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Non Operating Income across 6 years of filings, most recently posting $1802.7 for Q3 2025.
- Non Operating Income for Q3 2025 came in at $1802.7, up 108.05% year-over-year; the trailing twelve-month figure through Sep 2025 was -$178.5 million (changed 0.02% YoY), and the FY2022 annual result was -$178.3 million, down 107618.03% from the prior year.
- Non Operating Income came in at $1802.7 for Q3 2025 at Evotec SE, up from -$22382.8 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $144643.1 in Q3 2021 to a low of -$178.5 million in Q4 2022.
- The 5-year median for Non Operating Income is $1802.7 (2025), against an average of -$16.2 million.
- Across the five-year window, Non Operating Income jumped 1499.68% in 2021 and plunged 186149.07% in 2022, its largest moves.
- Evotec SE's Non Operating Income stood at -$95822.4 in 2021, then slumped by 186149.07% to -$178.5 million in 2022, then jumped by 100.01% to $19299.6 in 2023, then sank by 215.98% to -$22382.8 in 2024, then surged by 108.05% to $1802.7 in 2025.
- The last three Non Operating Income figures came in at $1802.7 (Q3 2025), -$22382.8 (Q3 2024), and $19299.6 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,802.68 |
| Sep 30, 2024 | -22,382.81 |
| Sep 30, 2023 | 19,299.62 |
| Dec 31, 2022 | -178.47 Mn |
| Sep 30, 2022 | 30,081.86 |
| Jun 30, 2022 | -21,945.09 |
| Mar 31, 2022 | -77,661.28 |
| Dec 31, 2021 | -95,822.44 |
| Sep 30, 2021 | 144,643.13 |
| Jun 30, 2021 | 70,387.26 |
| Mar 31, 2021 | 57,491.63 |
| Dec 31, 2020 | 532,882.03 |
| Sep 30, 2020 | -10,333.98 |